Search Results: immunotherapy

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• For Researchers

Mitochondrial DNA in cancer: small genome, big impact

Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics. Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.

5 May 2021

• Science & Technology

Meet the teams tackling 5 challenges in children’s and young people’s cancers

Joining forces with Children with Cancer UK, we’re proud to be co-funding the Cancer Research UK–Children with Cancer UK Innovation Awards. Joining forces with Children with Cancer UK, we’re proud to be co-funding the Cancer Research UK–Children with Cancer UK Innovation Awards.

18 March 2021

• Health & Medicine

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England. A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

9 February 2021

• For Researchers

2021: A bright future for cancer research

Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape. Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape.

28 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Science & Technology

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

9 November 2020

• Health & Medicine

News digest – lockdown, ovarian cancer blood test, statins and Government spending review

As many as 50,000 people in the UK have an undiagnosed cancer as a result of the disruption caused by coronavirus, according to Macmillan Cancer Support. As many as 50,000 people in the UK have an undiagnosed cancer as a result of the disruption caused by coronavirus, according to Macmillan Cancer Support.

31 October 2020